1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6766F0DE52606553F00258B5E002DDD7B
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/building-more-effective-medical-affairs-product-launch-teams-cardiology-pulmonology-segment?opendocument
18
19opendocument
2018.97.9.171
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25BMR




» Products & Services » » Medical Affairs » Launch Optimization

Building More Effective Medical Affairs Product Launch Teams: Cardiology and Pulmonology Segment

ID: POP-385


Features:

12 Info Graphics

33 Data Graphics

650+ Metrics

18 Narratives


Pages: 56


Published: 2024


Delivery Format: Shipped


 

License Options:


Buy Now

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • STUDY SNAPSHOT
  • KEY FINDINGS
  • VIEW TOC AND LIST OF EXHIBITS
In the large, competitive fields of Cardiology and Pulmonology, Medical Affairs teams are increasingly pivotal in the differentiation and successful launch of new products. Organizations are now integrating medical support and engagement strategies earlier in the product lifecycle, encompassing a range of high-impact programs and involving numerous internal and external stakeholders.

Best Practices, LLC undertook this benchmarking research to explore the evolving role of Medical Affairs in Cardiology and Pulmonology product launches. This report investigates evolving roles and responsibilities, cross-functional alignment, evidence dissemination strategies, performance metrics, resourcing, activities effectiveness, launch timeline, and digital launch tools deployment, all within the context of the Cardiology and Pulmonology therapeutic areas. In additition, the report examines the most critical success factors and challenges to achieving best-in-class launch preparedness for Cardiology and Pulmonology products.

Industries Profiled:
Pharmaceutical; Diagnostic; Biotech; Chemical; Health Care; Biopharmaceutical; Consulting; Consumer Products; Science


Companies Profiled:
AstraZeneca; BIAL; bioMerieux; Boehringer Ingelheim; Cardinal Health; Eurofarma; Genentech; Labaid Group; Matinas BioPharma; MEDiSTRAVA; Merck KGaA; Novartis; Pixacore; Pfizer; Thermo Fisher Scientific

Study Snapshot

Best Practices, LLC engaged 19 Medical leaders from 15 leading life sciences companies in this benchmarking research study. Medical Directors and VPs represent nearly four-fifths of the leaders who shared data and insights on Medical launch activities in this study.

Key topics covered in this report include:

  • Medical Leadership Roles and Launch Activity Effectiveness in Cardiology and Pulmonology
  • Ensuring Cross-functional Alignment and Collaboration in Cardiology and Pulmonology Launches
  • Medical Launch Evolution in Cardiology and Pulmonology Segment
  • Cardiology and Pulmonology Launch Activities Timeline, Performance Tracking, and Resourcing
  • Critical Success Factors and Major Pitfalls for Medical Affairs During Cardiology and Pulmonology Launches
  • Digital Launch Implementation and Impact in Cardiology and Pulmonology
  • Launch Tool Deployment for Cardiology and Pulmonology Products

Key Findings

Select key insights uncovered from this report are noted below. Detailed findings are available in the full report.

  • Internal Group Collaboration: Medical collaborates early and often with cross-functional launch teams (82%) through clearly defined roles, responsibilities, and expectations (65%) to ensure successful Cardiology and Pulmonology launches.
  • Launch Challenges: Poor cross-functional alignment and delayed involvement in launch activities are major pitfalls for Medical Affairs during launch.
Table of Contents

Sr. No.
Topic
Slide No.
I.
Executive SummaryPg. 4
II.
Section I: Launch Excellence and Medical’s Role & Activity EffectivenessPg. 6-12
III.
Section II: Ensuring Cross-functional Alignment and CollaborationPg. 13-15
IV.
Section III: Adopting to Ongoing Changes in Medical LandscapePg. 16-20
V.
Section IV: Launch Timeline, Preparedness Metrics, and ResourcingPg. 21-26
VI.
Section V: Critical Success Factors and Major PitfallsPg. 27-32
VII.
Section VI: Digital Influence on Launch Processes and Launch Tool DeploymentPg. 33-41
VIII.
Section VII: Participant DemographicsPg. 42-43
IX.
Section VIII: Detailed Benchmark Study DataPg. 44-55
X.
Section IX: About Best Practices, LLCPg. 56

    List of Charts & Exhibits

    I. Launch Excellence and Medical’s Role & Activity Effectiveness

    • Medical launch excellence framework
    • Medical Affairs’ role in Cardiology and Pulmonology launches
    • Medical leadership roles in Cardiology and Pulmonology launches
    • Medical Affairs’ effectiveness in Cardiology and Pulmonology launch activities
    • Most effective launch activities for Medical Affairs in Cardiology and Pulmonology
    • Improvement opportunities for Medical Affairs around Cardiology and Pulmonology launch activities

    II. Ensuring Cross-functional Alignment and Collaboration

    • Medical Affairs’ work with internal colleagues to ensure successful Cardiology and Pulmonology launches
    • Role of Medical Affairs group in cross-functional Cardiology and Pulmonology launch teams

    III. Adopting to Ongoing Changes in Medical Landscape

    • Change fronts for Medical launch evolution
    • Medical Affairs’ launch evolution around digital data dissemination and communication
    • Medical Affairs’ launch evolution around medical education
    • Medical Affairs’ launch evolution around organizational support

    IV. Launch Timeline, Preparedness Metrics and Resourcing

    • Medical Affairs’ Cardiology and Pulmonology launch activities timeline
    • Total annual Medical Affairs launch investment in U.S. dollars and number of FTEs for Cardiology and Pulmonology products during each of the years in launch phase
    • Launch dashboard and information used with the dashboard for Cardiology and Pulmonology
    • Percentage of total Medical Affairs launch investment allocated to each of the listed Medical Affairs activities in Cardiology and Pulmonology
    • Percentage of total Medical Affairs launch FTEs allocated to each of the listed Medical Affairs activities in Cardiology and Pulmonology

    V. Critical Success Factors and Major Pitfalls

    • Critical success factors for Medical Affairs in Cardiology and Pulmonology launches
    • Areas where advanced team planning is key for Cardiology and Pulmonology launches
    • Six critical areas for successful Medical Affairs launch readiness in Cardiology and Pulmonology
    • Major pitfalls for Medical Affairs during Cardiology and Pulmonology launches
    • Six major challenge areas for Medical Affairs during Cardiology and Pulmonology launches

    VI. Digital Influence on Launch Processes and Launch Tool Deployment

    • Post-pandemic digital technology utilization in Medical Affairs during Cardiology and Pulmonology product launches
    • Impact of digital technologies on current and future Cardiology and Pulmonology launch processes
    • Digital tools deployed by Medical Affairs during the Cardiology / Pulmonology product launch cycle
    • Impact of top three digital activities that Medical leads in Cardiology and Pulmonology
    • Impact of digital activities and programs used to support a successful Cardiology / Pulmonology product launch
    • Top digital tools that can bring success to Medical Affairs product launch activities
    • Fast-growing digital tools that are impacting Medicals’ launch strategy
    • Example of a valuable digital tool that supports launch activities

    VII. Participant Demographics

    • Geographic responsibility of benchmark partners

    VIII. Detailed Benchmark Study Data

    • Role served by Medical Affairs in Cardiology and Pulmonology product launches
    • Medical Affairs’ launch role effectiveness in Cardiology and Pulmonology
    • Role served by Medical Affairs in planning, research, and education activities in Cardiology and Pulmonology segment
    • Role served by Medical Affairs in data dissemination and organizational support activities in Cardiology and Pulmonology segment
    • Role served by Medical Affairs in research activities in Cardiology and Pulmonology segment
    • Role served by Medical Affairs in education and data dissemination support activities in Cardiology and Pulmonology segment
    • Role served by Medical Affairs in organizational support activities in Cardiology and Pulmonology segment
    • Medical Affairs launch activity involvement timeline - Evidence generation and field-based medical activities in Cardiology and Pulmonology
    • Medical Affairs launch activity involvement timeline - Medical information and medical regulatory activities in Cardiology and Pulmonology
    • Medical Affairs launch activity involvement timeline - HEOR activities and medical / scientific communications in Cardiology and Pulmonology
    • Medical Affairs launch activity involvement timeline - Independent medical education and external engagement activities in Cardiology and Pulmonology